This blog highlights research and development of new treatments, outcomes of global clinical trials and their regulations, with a special focus on ophthalmology and retinal diseases, including drugs and devices. The blog is meant for both clinical and pharmaceutical experts, as well as for patients / family members who are looking for information.
Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations at the American Academy of Ophthalmology Annual Meeting 2017 in New Orleans, LA. Stem cells injected into the eye appear to have replaced the missing cells damaged by the disease, with no serious side effects.
